维生素D相关基因单核苷酸多态性与HBV相关慢加急性肝衰竭的相关性分析

欧伟杰; 林烨鸿; 周卿; 商天宇; 林苏; 朱月永

doi:10.3969/j.issn.1001-5256.2019.06.025

维生素D相关基因单核苷酸多态性与HBV相关慢加急性肝衰竭的相关性分析

DOI: 10.3969/j.issn.1001-5256.2019.06.025

基金项目:

福建省医学创新课题(2016-CX-033)；福建省自然科学基金资助项目(2017J01187)；福建省科技计划项目(2016Y0040)；

详细信息

中图分类号: R575.3;R512.62
计量
- 文章访问数: 1535
- HTML全文浏览量: 64
- PDF下载量: 291
- 被引次数: 0
出版历程
- 收稿日期: 2019-01-03
- 出版日期: 2019-06-20

Association of vitamin D-related gene polymorphisms with hepatitis B virus-related acute-on-chronic liver failure

Research funding:

摘要

摘要:
目的探究维生素D相关基因单核苷酸多态性（SNP）在HBV相关慢加急性肝衰竭（ACLF）患者中的表达情况及其与HBV-ACLF短期预后的关系。方法纳入福建医科大学附属第一医院肝病中心于2012年7月-2018年3月收治的慢性乙型肝炎患者400例,根据其病程中是否发生ACLF,分为HBV-ACLF组（n=122）和Non-ACLF组（n=278）。分别收集两组患者的临床资料及实验室检查结果,同时采集外周血标本,应用imLDRTM多重SNP分型试剂盒检测维生素D受体（VDR）基因rs1544410、rs2228570及维生素D结合蛋白（VDBP）基因rs2282679共3个位点的SNP表达分型;并对HBV-ACLF组患者进行随访观察,追踪其3个月的生存情况。对比分析维生素D相关基因SNP与HBV-ACLF易感性及预后的关系。采用Hardy-Weinberg平衡检验评估各组基因样本的群体代表性。对于满足正态分布的计量资料,2组间比较采用t检验;对于不满足正态分布的计量资料,2组间比较采用Mann-Whitney U检验。SNP与HBV-ACLF发生的相对风险度采用多元logistic回归分析。...
- 受体,骨化三醇 /
- 维生素D结合蛋白质 /
- 乙型肝炎病毒 /
- 慢加急性肝功能衰竭 /
- 多态性,单核苷酸
Abstract:
Objective To investigate the expression of single nucleotide polymorphisms (SNP) of vitamin D-related genes in patients with hepatitis B-related acute-on-chronic liver failure (HBV-ACLF) and its association with short-term prognosis of HBV-ACLF. Methods The patients with chronic hepatitis B who were admitted to Liver Diseases Research Center, The First Affiliated Hospital of Fujian Medical University, from July 2012 to March 2018 were enrolled, and according to the presence or absence of acute-on-chronic liver failure during the course of the disease (n = 400) , they were divided into HBV-ACLF group (n = 122) and non-ACLF group (n = 278) . The clinical data and laboratory examination results were collected; peripheral blood samples were collected, and imLDRTM multiple SNP typing kit was used to determine the genotypes of the SNPs of vitamin D receptor (VDR) rs1544410 and rs2228570 and vitamin D-binding protein (VDBP) rs2282679. The patients in the HBV-ACLF group were followed up for 3 months to observe their survival. The association of vitamin D-related gene SNP with HBV-ACLF susceptibility and prognosis was analyzed. Hardy-Weinberg equilibrium was used to evaluate the representativeness of gene samples. The t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups. A logistic regression analysis was used to investigate the odds ratio of SNP in the development of HBV-ACLF. Results There were no significant differences in the genotype and allele frequencies of VDR rs1544410 and rs2228570 and VDBP rs2282679 between the HBV-ACLF group and the non-ACLF group (all P > 0. 05) . In addition, there were also no significant differences in the genotype and allele frequencies of VDR rs1544410 and rs2228570 and VDBP rs2282679 between the HBV-ACLF patients who survived and those who died (all P > 0. 05) . Conclusion SNPs of VDR rs1544410 and rs2228570 and VDBP rs2282679 are not associated with the development and short-term prognosis of HBV-ACLF.
- receptor, calcitriol /
- vitamin D-binding protein /
- hepatitis B virus /
- acute-on-chronic liver failure /
- polymorphism, single nucleotide

HTML全文

参考文献(23)

[1]SARIN SK, KUMAR A, ALMEIDA JA, et al.Acute-on-chronic liver failure:Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) [J].Hepatol Int, 2009, 3 (1) :269-282.

[2]ZHANG DJ, ZHOU B, HOU JL.Research progress in prognostic models of acute-on-chronic liver failure[J].J Clin Hepatol, 2018, 34 (6) :1351-1356. (in Chinese) 张东敬, 周彬, 侯金林.慢加急性肝衰竭预后模型的研究进展[J].临床肝胆病杂志, 2018, 34 (6) :1351-1356.

[3]ZHAO RH, SHI Y, ZHAO H, et al.Acute-on-chronic liver failure in chronic hepatitis B:An update[J].Expert Rev Gastroenterol Hepatol, 2018, 12 (4) :341-350.

[4]BASIT S.Vitamin D in health and disease:A literature review[J].Br J Biomed Sci, 2013, 70 (4) :161-172

[5]WANG YL, LIU CY, WANG J, et al.Correlation of peripheral blood 25 (OH) D with T lymphocyte subsets and interferon-αin patients with systemic lupus erythematosus[J].Clin J Med Offic, 2017, 45 (11) :1199-1201, 1210. (in Chinese) 王医林, 刘英纯, 王健, 等.系统性红斑狼疮患者外周血25 (OH) D与T淋巴细胞亚群及IFN-α关系研究[J].临床军医杂志, 2017, 45 (11) :1199-1201, 1210.

[6]KEANE JT, ELANGOVAN H, STOKES RA, et al.Vitamin Dand the liver-correlation or cause?[J].Nutrients, 2018, 10 (4) :496.

[7]ARTEH J, NARRA S, NAIR S.Prevalence of vitamin D deficiency in chronic liver disease[J].Dig Dis Sci, 2010, 55 (9) :2624-2628.

[8]FARNIK H, BOJUNGA J, BERGER A, et al.Low vitamin D serum concentration is associated with high levels of hepatitis Bvirus replication in chronically infected patients[J].Hepatology, 2013, 58 (4) :1270-1276.

[9]HOAN NX, KHUYEN N, BINH MT, et al.Association of vitamin D deficiency with hepatitis B virus-related liver diseases[J].BMC Infect Dis, 2016, 16 (1) :507.

[10]WANG TJ, ZHANG F, RICHARDS JB, et al.Common genetic determinants of vitamin D insufficiency:A genome-wide association study[J].Lancet, 2010, 376 (9736) :180-188.

[11]HE Q, HUANG Y, ZHANG L, et al.Association between vitamin D receptor polymorphisms and hepatitis B virus infection susceptibility:A meta-analysis study[J].Gene, 2018, 645:105-112.

[12]BOGLIONE L, CUSATO J, DE NICOLO A, et al.Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis BHBe Ag negative with PEG-interferon[J].J Viral Hepat, 2015, 22 (3) :318-327.

[13]HUANG YW, LIAO YT, CHEN W, et al.Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan[J].Genes Immun, 2010, 11 (1) :87-93.

[14]PENG Q, YANG S, LAO X, et al.Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population[J].PLo S One, 2014, 9 (12) :e116026.

[15]LI YJ, TANG YW, SHI YQ, et al.Polymorphisms in the vitamin Dreceptor gene and risk of primary biliary cirrhosis:A meta-analysis[J].J Gastroenterol Hepatol, 2014, 29 (4) :706-715.

[16]BAUR K, MERTENS JC, SCHMITT J, et al.Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCVpatients[J].Liver Int, 2012, 32 (4) :635-643.

[17]LIMOTHAI U, CHUAYPEN N, KHLAIPHUENGSIN A, et al.Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis B[J].Antivir Ther, 2017, 22 (8) :681-688.

[18]SHAKER O, NASSAR Y, AYOUB S, et al.Impact of Fok I (rs10735810) and Bsm I (rs1544410) on treatment of chronic HCV patients with genotype 4[J].J Clin Lab Anal, 2016, 30 (6) :1021-1027.

[19]GIBSON PS, QUAGLIA A, DHAWAN A, et al.Vitamin D status and associated genetic polymorphisms in a cohort of UKchildren with non-alcoholic fatty liver disease[J].Pediatr Obes, 2018, 13 (7) :433-441.

[20]KEMPINSKA-PODHORODECKA A, MILKIEWICZ M, JABLONSKID, et al.ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis[J].PLo S One, 2017, 12 (4) :e0176264.

[21]KARATAYLI SC, ULGER ZE, ERGUL AA, et al.Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta[J].J Viral Hepat, 2014, 21 (4) :297-304.

[22]MATEOS-MUNOZ B, GARCIA-MARTIN E, TORREJON MJ, et al.GC gene polymorphism and unbound serum retinolbinding protein 4 are related to the risk of insulin resistance in patients with chronic hepatitis C:A prospective cross-sectional study[J].Medicine, 2016, 95 (10) :e3019.

[23]YU R, TAN D, NING Q, et al.Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B[J].Hepatol Res, 2018, 48 (3) :e213-e221.

施引文献

资源附件(0)

访问统计